Crossref
journal-article
Elsevier BV
Virology (78)
References
71
Referenced
112
10.4049/jimmunol.163.12.6756
/ J. Immunol. / A DNA immunization model study with constructs expressing the Tick-Borne Encephalitis virus envelope protein E in different physical forms by Aberle (1999)10.1016/S0042-6822(95)80018-2
/ Virology / Glycosylation and antigenic variation among Kunjin virus isolates by Adams (1995)10.1086/376871
/ J. Infect. Dis. / Human immunoglobulin as a treatment for West Nile virus infection by Agrawal (2003)10.1128/JVI.69.9.5816-5820.1995
/ J. Virol. / Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form by Allison (1995)10.1128/JVI.69.2.695-700.1995
/ J. Virol. / Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH by Allison (1995)10.1128/JVI.75.9.4268-4275.2001
/ J. Virol. / Mutational evidence for an internal fusion peptide in flavivirus envelope protein E by Allison (2001)10.1111/j.1749-6632.2001.tb02702.x
/ Ann. N. Y. Acad. Sci. / Current status of flavivirus vaccines by Barrett (2001)10.1128/JVI.76.24.13097-13100.2002
/ J. Virol. / Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein by Beasley (2002)10.1086/376870
/ J. Infect. Dis. / Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice by Ben-Nathan (2003)10.1099/0022-1317-78-9-2293
/ J. Gen. Virol. / Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses by Berthet (1997)10.1007/BF01311025
/ Arch. Virol. / Antigenic analysis of West Nile virus strains using monoclonal antibodies by Besselaar (1988)10.1128/JVI.75.8.4002-4007.2001
/ J. Virol. / Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein by Bhardwaj (2001)10.1038/sj.emboj.7600064
/ EMBO J. / Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation by Bressanelli (2004)10.4269/ajtmh.1998.58.389
/ Am. J. Trop. Med. Hyg. / Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E by Butrapet (1998)10.1093/infdis/130.6.634
/ J. Infect. Dis. / Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors by Camenga (1974)10.1099/0022-1317-79-10-2375
/ J. Gen. Virol. / West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness by Chambers (1998)10.1128/JVI.74.9.4244-4252.2000
/ J. Virol. / A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice by Chang (2000)10.1128/JVI.75.16.7769-7773.2001
/ J. Virol. / Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells by Crill (2001)10.1128/JVI.75.9.4040-4047.2001
/ J. Virol. / West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays by Davis (2001)10.1128/JVI.77.4.2578-2586.2003
/ J. Virol. / B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus by Diamond (2003){'key': '10.1016/j.virol.2005.02.020_bib20', 'first-page': '16.17.11', 'article-title': 'Generation of recombinant vaccinia viruses', 'volume': 'vol. 2', 'author': 'Earl', 'year': '1993'}
/ Generation of recombinant vaccinia viruses by Earl (1993)10.3201/eid0704.017408
/ Emerging Infect. Dis. / Partial genetic characterization of West Nile virus strains, New York State, 2000 by Ebel (2001)10.1128/JVI.77.24.12941-12949.2003
/ J. Virol. / Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice by Engle (2003)10.1038/321244a0
/ Nature / A new mechanism for the neutralization of enveloped viruses by antiviral antibody by Gollins (1986)10.1099/0022-1317-72-6-1323
/ J. Gen. Virol. / Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions by Guirakhoo (1991)10.1007/BF01309481
/ Arch. Virol. / Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice by Halevy (1994)10.1086/377172
/ Clin. Infect Dis. / The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis by Haley (2003)10.1038/icb.1991.7
/ Immunol. Cell Biol. / Monoclonal antibodies to Kunjin and Kokobera viruses by Hall (1991)10.1034/j.1399-3062.2002.01014.x
/ Transpl. Infect Dis. / Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis by Hamdan (2002)10.1002/jmv.1890450417
/ J. Med. Virol. / Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2 by He (1995)10.1016/S0065-3527(00)55005-2
/ Adv. Virus Res. / Structures and mechanisms in flavivirus fusion by Heinz (2000)10.1128/JVI.65.10.5579-5583.1991
/ J. Virol. / The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization by Heinz (1991)10.1016/0264-410X(95)00133-L
/ Vaccine / Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis by Heinz (1995)10.1128/JVI.78.1.378-388.2004
/ J. Virol. / An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells by Hung (2004)10.1016/S0166-0934(01)00346-9
/ J. Virol. Methods / A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen by Hunt (2001)10.1099/0022-1317-83-9-2091
/ J. Gen. Virol. / Occupancy and mechanism in antibody-mediated neutralization of animal viruses by Klasse (2002)10.1016/S0264-410X(01)00446-7
/ Vaccine / Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine by Konishi (2002)10.1128/JVI.67.3.1672-1675.1993
/ J. Virol. / Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein by Konishi (1993)10.1016/0042-6822(92)90526-U
/ Virology / Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection by Konishi (1992)10.1128/JVI.75.5.2204-2212.2001
/ J. Virol. / Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles by Konishi (2001)10.1007/s00705-002-0809-3
/ Arch. Virol. / Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus by Kroeger (2002)10.1016/S0092-8674(02)00660-8
/ Cell / Structure of dengue virus: implications for flavivirus organization, maturation, and fusion by Kuhn (2002)10.1126/science.286.5448.2333
/ Science / Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States by Lanciotti (1999)10.1128/JVI.76.11.5480-5491.2002
/ J. Virol. / Folding and dimerization of Tick-Borne Encephalitis virus envelope proteins prM and E in the endoplasmic reticulum by Lorenz (2002)10.1128/JVI.75.22.10787-10799.2001
/ J. Virol. / Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively by Mackenzie (2001)10.1016/0042-6822(91)90034-9
/ Virology / Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection by Mason (1991)10.1016/0923-2516(90)90085-W
/ Res. Virol. / Comparative analysis of West Nile virus strains isolated from human and animal hosts using monoclonal antibodies and cDNA restriction digest profiles by Mathiot (1990)10.1073/pnas.0832193100
/ Proc. Natl. Acad. Sci. U. S. A. / A ligand-binding pocket in the dengue virus envelope glycoprotein by Modis (2003)10.1038/nature02165
/ Nature / Structure of the dengue virus envelope protein after membrane fusion by Modis (2004)10.1126/science.1089316
/ Science / Structure of West Nile virus by Mukhopadhyay (2003)10.1016/j.antiviral.2003.08.001
/ Antiviral Res. / Vaccines and animal models for arboviral encephalitides by Nalca (2003){'key': '10.1016/j.virol.2005.02.020_bib51', 'first-page': '221', 'article-title': 'Equine vaccine for West Nile virus', 'volume': '114', 'author': 'Ng', 'year': '2003', 'journal-title': 'Dev. Biol. (Basel)'}
/ Dev. Biol. (Basel) / Equine vaccine for West Nile virus by Ng (2003)10.1099/0022-1317-58-2-283
/ J. Gen. Virol. / Monoclonal antibodies against the flavivirus West Nile by Peiris (1982)10.1016/S0264-410X(99)00570-8
/ Vaccine / Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein by Raviprakash (2000)10.1038/375291a0
/ Nature / The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution by Rey (1995)10.1016/S0065-3527(03)59005-4
/ Adv. Virus Res. / Antigenic structure of flavivirus proteins by Roehrig (2003)10.1006/viro.1998.9200
/ Virology / Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica by Roehrig (1998)10.1016/S0968-0004(00)89080-5
/ Trends Biochem. Sci. / RASMOL: biomolecular graphics for all by Sayle (1995)10.1128/JVI.70.7.4549-4557.1996
/ J. Virol. / Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions by Schalich (1996)10.3201/eid0704.017432
/ Emerging Infect. Dis. / Treatment of West Nile virus encephalitis with intravenous immunoglobulin by Shimoni (2001)10.1128/JVI.71.11.8475-8481.1997
/ J. Virol. / Proteolytic activation of tick-borne encephalitis virus by furin by Stadler (1997)10.1128/JVI.76.8.3784-3790.2002
/ J. Virol. / Membrane interactions of the Tick-Borne Encephalitis virus fusion protein E at low pH by Stiasny (2002)10.3201/eid0812.020229
/ Emerging Infect. Dis. / Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model by Tesh (2002)10.1074/jbc.M402385200
/ J. Biol. Chem. / Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile Virus by Volk (2004)10.4049/jimmunol.167.9.5273
/ J. Immunol. / Immunization of mice against West Nile virus with recombinant envelope protein by Wang (2001)10.1128/JVI.63.6.2521-2526.1989
/ J. Virol. / Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release by Wengler (1989)10.1074/jbc.M307776200
/ J. Biol. Chem. / Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein by Wu (2003)10.1006/viro.2000.0795
/ Virology / An infectious clone of the West Nile flavivirus by Yamshchikov (2001){'key': '10.1016/j.virol.2005.02.020_bib68', 'first-page': '2.5.2', 'article-title': 'Production of monoclonal antibodies', 'volume': 'vol. 1', 'author': 'Yokoyama', 'year': '1994'}
/ Production of monoclonal antibodies by Yokoyama (1994)10.1021/bi049324g
/ Biochemistry / Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses by Yu (2004)10.1093/emboj/cdg270
/ EMBO J. / Structures of immature flavivirus particles by Zhang (2003)
Dates
Type | When |
---|---|
Created | 20 years, 4 months ago (April 9, 2005, 7:46 a.m.) |
Deposited | 2 years, 4 months ago (May 2, 2023, 5:32 p.m.) |
Indexed | 11 months, 2 weeks ago (Sept. 19, 2024, 11:02 a.m.) |
Issued | 20 years, 4 months ago (May 1, 2005) |
Published | 20 years, 4 months ago (May 1, 2005) |
Published Print | 20 years, 4 months ago (May 1, 2005) |
@article{S_nchez_2005, title={Characterization of neutralizing antibodies to West Nile virus}, volume={336}, ISSN={0042-6822}, url={http://dx.doi.org/10.1016/j.virol.2005.02.020}, DOI={10.1016/j.virol.2005.02.020}, number={1}, journal={Virology}, publisher={Elsevier BV}, author={Sánchez, Melissa D. and Pierson, Theodore C. and McAllister, Douglas and Hanna, Sheri L. and Puffer, Bridget A. and Valentine, Laura E. and Murtadha, Mariam M. and Hoxie, James A. and Doms, Robert W.}, year={2005}, month=may, pages={70–82} }